Cargando…
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support
Testicular cancer is the most common tumor in young males aged 15–40 years. The overall cure rate for men with testicular cancer is >90%, so a huge number of these patients will become testicular cancer survivors. These people may feel some stress in the experience of diagnosis, treatment, and co...
Autores principales: | De Padova, Silvia, Casadei, Chiara, Berardi, Alejandra, Bertelli, Tatiana, Filograna, Alessia, Cursano, Maria Concetta, Menna, Cecilia, Burgio, Salvatore Luca, Altavilla, Amelia, Schepisi, Giuseppe, Prati, Sabrina, Montalti, Sandra, Chovanec, Michal, Banna, Giuseppe Luigi, Grassi, Luigi, Mego, Michal, De Giorgi, Ugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546807/ https://www.ncbi.nlm.nih.gov/pubmed/31191451 http://dx.doi.org/10.3389/fendo.2019.00318 |
Ejemplares similares
-
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer
por: Bleve, Sara, et al.
Publicado: (2022) -
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
por: Cursano, Maria Concetta, et al.
Publicado: (2020) -
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review
por: Schepisi, Giuseppe, et al.
Publicado: (2021) -
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2019) -
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2023)